You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

LGMDR4

Showing 1 - 7 of 7
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

LGMDR9 Trial in Copenhagen, Paris, Newcastle Upon Tyne (GNT0006, Day 0: Placebo, Day 0: GNT0006)

Recruiting
  • LGMDR9
  • GNT0006
  • +4 more
  • Copenhagen, Denmark
  • +2 more
Oct 21, 2022

LGMD2C Trial (ATA-200)

Not yet recruiting
  • LGMD2C
  • ATA-200
  • (no location specified)
Aug 1, 2023

Limb-Girdle Muscular Dystrophy, Type 2E Trial in Columbus (SRP-9003)

Active, not recruiting
  • Limb-Girdle Muscular Dystrophy, Type 2E
  • SRP-9003
  • Columbus, Ohio
    Nationwide Children's Hospital
Sep 28, 2022

Trial Readiness and Endpoint Assessment in LGMD R1

Not yet recruiting
  • Calpain-3 Deficiency Limb Girdle Muscular Dystrophy Type 2A
  • +3 more
    • Richmond, Virginia
      Virginia Commonwealth University
    Jan 10, 2023

    MRI-phenotyping of Patients With Pathogenic Anoctamin 5 Variants

    Recruiting
    • Limb Girdle Muscular Dystrophy
    • No intervention
    • Copenhagen, Denmark
      Nanna Scharff Poulsen
    Jan 17, 2023

    Dysferlinopathy, Miyoshi Myopathy, LGMDR2 Trial in Moscow

    Enrolling by invitation
    • Dysferlinopathy
    • +3 more
      • Moscow, Russian Federation
        Human Stem Cells Institute
      Jul 25, 2022

      Congenital Muscular Dystrophy With ITGA7 (Integrin Alpha-7) Deficiency, Alpha-Dystroglycanopathy (Congenital Muscular Dystrophy

      Recruiting
      • Congenital Muscular Dystrophy With ITGA7 (Integrin Alpha-7) Deficiency
      • +51 more
        • Lakewood, California
          Congenital Muscle Disease International Registry (www.cmdir.org)
        Aug 3, 2021